Literature DB >> 29794832

Preference for injectable over oral HIV pre-exposure prophylaxis in public-sector primary-care clinics in Swaziland.

Mark J Siedner1,2,3,4, Anita Hettema5, Allison Hughey5, Catherine E Oldenburg6, Stefan Kohler7, Kate Bärnighausen7, Shannon McMahon7,8, Chuan Jia7, Charlotte Lejeune5, Sindy Matse9, Till Bärnighausen4,7.   

Abstract

: Long-acting injectable (LAI) HIV pre-exposure prophylaxis (PrEP) may mitigate adherence challenges reported by young women in Southern Africa. We assessed preferences for PrEP in public-sector, primary care clinics in Swaziland. Among surveyed respondents, 75% (95% confidence interval = 65-83%) stated preference for LAI over oral PrEP; with no differences by sex, age, or sexual behavior (all P > 0.05). Notably, over 70% (95% confidence interval 58-82%) with current use of oral PrEP also stated preference for LAI PrEP.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29794832      PMCID： PMC6717317          DOI： 10.1097/QAD.0000000000001859

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  3 in total

1.  Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study.

Authors:  Yehuda Z Cohen; Allison L Butler; Katrina Millard; Maggi Witmer-Pack; Rebeka Levin; Cecilia Unson-O'Brien; Roshni Patel; Irina Shimeliovich; Julio C C Lorenzi; Jill Horowitz; Stephen R Walsh; Shu Lin; Joshua A Weiner; Anna Tse; Alicia Sato; Chelsey Bennett; Bryan Mayer; Kelly E Seaton; Nicole L Yates; Lindsey R Baden; Allan C deCamp; Margaret E Ackerman; Michael S Seaman; Georgia D Tomaras; Michel C Nussenzweig; Marina Caskey
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.752

2.  Acceptability of a long-acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076).

Authors:  Elizabeth E Tolley; Sue Li; Sahar Z Zangeneh; Millicent Atujuna; Petina Musara; Jessica Justman; Subash Pathak; Linda-Gail Bekker; Shobha Swaminathan; Jill Stanton; Jennifer Farrior; Nirupama Sista
Journal:  J Int AIDS Soc       Date:  2019-10       Impact factor: 5.396

3.  "It's hard for us men to go to the clinic. We naturally have a fear of hospitals." Men's risk perceptions, experiences and program preferences for PrEP: A mixed methods study in Eswatini.

Authors:  Astrid Berner-Rodoreda; Pascal Geldsetzer; Kate Bärnighausen; Anita Hettema; Till Bärnighausen; Sindy Matse; Shannon A McMahon
Journal:  PLoS One       Date:  2020-09-23       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.